2022-12-012023-11-302023-11-30false09317076HUMANITY COSMETICS LIMITED2024-09-1946450iso4217:GBPxbrli:pure093170762022-12-01093170762023-11-30093170762022-12-012023-11-30093170762021-12-01093170762022-11-30093170762021-12-012022-11-3009317076bus:SmallEntities2022-12-012023-11-3009317076bus:AuditExempt-NoAccountantsReport2022-12-012023-11-3009317076bus:AbridgedAccounts2022-12-012023-11-3009317076bus:PrivateLimitedCompanyLtd2022-12-012023-11-3009317076core:WithinOneYear2023-11-3009317076core:AfterOneYear2023-11-3009317076core:WithinOneYear2022-11-3009317076core:AfterOneYear2022-11-3009317076core:ShareCapital2023-11-3009317076core:SharePremium2023-11-3009317076core:RevaluationReserve2023-11-3009317076core:OtherReservesSubtotal2023-11-3009317076core:RetainedEarningsAccumulatedLosses2023-11-3009317076core:ShareCapital2022-11-3009317076core:SharePremium2022-11-3009317076core:RevaluationReserve2022-11-3009317076core:OtherReservesSubtotal2022-11-3009317076core:RetainedEarningsAccumulatedLosses2022-11-3009317076core:LandBuildings2023-11-3009317076core:PlantMachinery2023-11-3009317076core:Vehicles2023-11-3009317076core:FurnitureFittings2023-11-3009317076core:OfficeEquipment2023-11-3009317076core:NetGoodwill2023-11-3009317076core:IntangibleAssetsOtherThanGoodwill2023-11-3009317076core:ListedExchangeTraded2023-11-3009317076core:UnlistedNon-exchangeTraded2023-11-3009317076core:LandBuildings2022-11-3009317076core:PlantMachinery2022-11-3009317076core:Vehicles2022-11-3009317076core:FurnitureFittings2022-11-3009317076core:OfficeEquipment2022-11-3009317076core:NetGoodwill2022-11-3009317076core:IntangibleAssetsOtherThanGoodwill2022-11-3009317076core:ListedExchangeTraded2022-11-3009317076core:UnlistedNon-exchangeTraded2022-11-3009317076core:LandBuildings2022-12-012023-11-3009317076core:PlantMachinery2022-12-012023-11-3009317076core:Vehicles2022-12-012023-11-3009317076core:FurnitureFittings2022-12-012023-11-3009317076core:OfficeEquipment2022-12-012023-11-3009317076core:NetGoodwill2022-12-012023-11-3009317076core:IntangibleAssetsOtherThanGoodwill2022-12-012023-11-3009317076core:ListedExchangeTraded2022-12-012023-11-3009317076core:UnlistedNon-exchangeTraded2022-12-012023-11-3009317076core:MoreThanFiveYears2022-12-012023-11-3009317076core:Non-currentFinancialInstruments2023-11-3009317076core:Non-currentFinancialInstruments2022-11-3009317076dpl:CostSales2022-12-012023-11-3009317076dpl:DistributionCosts2022-12-012023-11-3009317076core:LandBuildings2022-12-012023-11-3009317076core:PlantMachinery2022-12-012023-11-3009317076core:Vehicles2022-12-012023-11-3009317076core:FurnitureFittings2022-12-012023-11-3009317076core:OfficeEquipment2022-12-012023-11-3009317076dpl:AdministrativeExpenses2022-12-012023-11-3009317076core:NetGoodwill2022-12-012023-11-3009317076core:IntangibleAssetsOtherThanGoodwill2022-12-012023-11-3009317076dpl:GroupUndertakings2022-12-012023-11-3009317076dpl:ParticipatingInterests2022-12-012023-11-3009317076dpl:GroupUndertakingscore:ListedExchangeTraded2022-12-012023-11-3009317076core:ListedExchangeTraded2022-12-012023-11-3009317076dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-12-012023-11-3009317076core:UnlistedNon-exchangeTraded2022-12-012023-11-3009317076dpl:CostSales2021-12-012022-11-3009317076dpl:DistributionCosts2021-12-012022-11-3009317076core:LandBuildings2021-12-012022-11-3009317076core:PlantMachinery2021-12-012022-11-3009317076core:Vehicles2021-12-012022-11-3009317076core:FurnitureFittings2021-12-012022-11-3009317076core:OfficeEquipment2021-12-012022-11-3009317076dpl:AdministrativeExpenses2021-12-012022-11-3009317076core:NetGoodwill2021-12-012022-11-3009317076core:IntangibleAssetsOtherThanGoodwill2021-12-012022-11-3009317076dpl:GroupUndertakings2021-12-012022-11-3009317076dpl:ParticipatingInterests2021-12-012022-11-3009317076dpl:GroupUndertakingscore:ListedExchangeTraded2021-12-012022-11-3009317076core:ListedExchangeTraded2021-12-012022-11-3009317076dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-12-012022-11-3009317076core:UnlistedNon-exchangeTraded2021-12-012022-11-3009317076core:NetGoodwill2023-11-3009317076core:IntangibleAssetsOtherThanGoodwill2023-11-3009317076core:LandBuildings2023-11-3009317076core:PlantMachinery2023-11-3009317076core:Vehicles2023-11-3009317076core:FurnitureFittings2023-11-3009317076core:OfficeEquipment2023-11-3009317076core:AfterOneYear2023-11-3009317076core:WithinOneYear2023-11-3009317076core:ListedExchangeTraded2023-11-3009317076core:UnlistedNon-exchangeTraded2023-11-3009317076core:ShareCapital2023-11-3009317076core:SharePremium2023-11-3009317076core:RevaluationReserve2023-11-3009317076core:OtherReservesSubtotal2023-11-3009317076core:RetainedEarningsAccumulatedLosses2023-11-3009317076core:NetGoodwill2022-11-3009317076core:IntangibleAssetsOtherThanGoodwill2022-11-3009317076core:LandBuildings2022-11-3009317076core:PlantMachinery2022-11-3009317076core:Vehicles2022-11-3009317076core:FurnitureFittings2022-11-3009317076core:OfficeEquipment2022-11-3009317076core:AfterOneYear2022-11-3009317076core:WithinOneYear2022-11-3009317076core:ListedExchangeTraded2022-11-3009317076core:UnlistedNon-exchangeTraded2022-11-3009317076core:ShareCapital2022-11-3009317076core:SharePremium2022-11-3009317076core:RevaluationReserve2022-11-3009317076core:OtherReservesSubtotal2022-11-3009317076core:RetainedEarningsAccumulatedLosses2022-11-3009317076core:NetGoodwill2021-12-0109317076core:IntangibleAssetsOtherThanGoodwill2021-12-0109317076core:LandBuildings2021-12-0109317076core:PlantMachinery2021-12-0109317076core:Vehicles2021-12-0109317076core:FurnitureFittings2021-12-0109317076core:OfficeEquipment2021-12-0109317076core:AfterOneYear2021-12-0109317076core:WithinOneYear2021-12-0109317076core:ListedExchangeTraded2021-12-0109317076core:UnlistedNon-exchangeTraded2021-12-0109317076core:ShareCapital2021-12-0109317076core:SharePremium2021-12-0109317076core:RevaluationReserve2021-12-0109317076core:OtherReservesSubtotal2021-12-0109317076core:RetainedEarningsAccumulatedLosses2021-12-0109317076core:AfterOneYear2022-12-012023-11-3009317076core:WithinOneYear2022-12-012023-11-3009317076core:Non-currentFinancialInstrumentscore:CostValuation2022-12-012023-11-3009317076core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-12-012023-11-3009317076core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-12-012023-11-3009317076core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-12-012023-11-3009317076core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-12-012023-11-3009317076core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-12-012023-11-3009317076core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-12-012023-11-3009317076core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-12-012023-11-3009317076core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-12-012023-11-3009317076core:Non-currentFinancialInstrumentscore:CostValuation2023-11-3009317076core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-11-3009317076core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-11-3009317076core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-11-3009317076core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-11-3009317076core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-11-3009317076core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-11-3009317076core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-11-3009317076core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-11-3009317076core:Non-currentFinancialInstrumentscore:CostValuation2022-11-3009317076core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-11-3009317076core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-11-3009317076core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-11-3009317076core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-11-3009317076core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-11-3009317076core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-11-3009317076core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-11-3009317076core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-11-3009317076bus:Director12022-12-012023-11-3009317076bus:Director22022-12-012023-11-30

HUMANITY COSMETICS LIMITED

Registered Number
09317076
(England and Wales)

Unaudited Financial Statements for the Year ended
30 November 2023

HUMANITY COSMETICS LIMITED
Company Information
for the year from 1 December 2022 to 30 November 2023

Directors

Gerald Floyd
Christopher Reid

Company Secretary

Christopher Reid

Registered Address

Office 9 Dalton House
60 Windsor Avenue
London
SW19 2RR

Registered Number

09317076 (England and Wales)
HUMANITY COSMETICS LIMITED
Statement of Financial Position
30 November 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets3-364
-364
Current assets
Stocks52,89654,176
Debtors8644,354
Cash at bank and on hand3,99110,588
57,75169,118
Creditors amounts falling due within one year(150,229)(121,013)
Net current assets (liabilities)(92,478)(51,895)
Total assets less current liabilities(92,478)(51,531)
Creditors amounts falling due after one year(6,800)(8,126)
Net assets(99,278)(59,657)
Capital and reserves
Called up share capital22
Profit and loss account(99,280)(59,659)
Shareholders' funds(99,278)(59,657)
The financial statements were approved and authorised for issue by the Board of Directors on 19 September 2024, and are signed on its behalf by:
Gerald Floyd
Director
Registered Company No. 09317076
HUMANITY COSMETICS LIMITED
Notes to the Financial Statements
for the year ended 30 November 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows: Plant & Machinery - Straight Line 20%
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
2.Average number of employees

20232022
Average number of employees during the year22
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 December 221,820
At 30 November 231,820
Depreciation and impairment
At 01 December 221,456
Charge for year364
At 30 November 231,820
Net book value
At 30 November 23-
At 30 November 22364